Home / Without Label / CLLS Cellectis S.A. gains 31% Dec 30, 2019

Monday, December 30, 2019

CLLS Cellectis S.A. gains 31% Dec 30, 2019

priceSeries Monday, December 30, 2019 0 Comment

Developing cancer immunotherapies based on gene-edited CAR T-cells.http://www.priceseries.com/trade/CLLS-Cellectis-SA-stock-gains-31-percent-a-Trade-Record-by-priceSeries-2019112120191230.html

Posted by : priceSeries Monday, December 30, 2019

No Comments

Subscribe to: Post Comments (Atom)